Gener8 Announces Closing of The Second Tranche Of Brokered Private Placement

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / October 6, 2014 / Gener8 Media Corp. GNR ("Gener8" or the "Company") is pleased to announce that on September 30, 2014 it closed another round of its brokered private placement (the "Financing"). This round of the Financing, previously announced in a press release dated September 16, 2014, consists of the issuance of 822,500 Units at a price of $0.75 per Unit for gross proceeds of $616,875, for a total issuance to date from the Financing of 1,984,000 Units for gross proceeds of $1,488,000. Each Unit consists of one common share in the capital of the Company and one-half of one common share purchase warrant. Each whole warrant entitles the holder to acquire one common share at a price of $1.00 until March 31, 2016.

In connection with this round of the Financing, the Company paid Canaccord Genuity Corp. aggregate cash commissions of approximately $43,181, issued an aggregate of 57,575 agent's warrants, plus 13,711 common shares and 6,855 agent's warrants representing the corporate finance fee. Each agent warrant is exercisable into one common share at a price of $1.00 per common share until March 31, 2016.

Proceeds from the Financing are expected to be used for general working capital expenditures across all business units of the Company including Cumul8, Reelhouse and the 3D studio. All securities issued in connection with this round of the Financing are subject to a four-month resale restriction expiring January 31, 2015.

Subscriptions continue to be received by the Company, and a final round in connection with the Financing will be completed on or before October 31, 2014.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Gener8

Gener8 Media Corp. is a media technology company led by a team of gaming industry veterans. At the forefront of postproduction, the Company earned its stripes by developing a proprietary 3D conversion technology, garnering high-profile credits including "300: Rise of an Empire," "Godzilla," and "Maleficent". Gener8 has since expanded into offering visual effects services and a cloud-based data management and analytics solution called Cumul8. With its focus on developing disruptive solutions that combine design and technology, Gener8 funded and then acquired a majority interest in Reelhouse Media Ltd., an online entertainment distribution start-up. Gener8's head office is located in Vancouver, British Columbia and currently has over 200 employees. Visit the company website at www.gener8.com.

ON BEHALF OF THE BOARD OF THE COMPANY

"Rory Armes"
Rory Armes
Chief Executive Officer and Director

FOR MORE INFORMATION, PLEASE CONTACT:

Danielle Rockel
Vice President of Corporate Affairs
Danielle@gener8.com
604-669-8885

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Except for statements of historical fact, this news release contains certain forward-looking statements within the meaning of applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" occur. In particular, forward-looking statements in this press release include statements with respect to the closing of the brokered private placement and closing of the transaction with Tianjin Fu Feng Da Movie & TV Technology Investment and Development Co., Ltd.("FFD"). Although Gener8 believes that the expectations reflected in the forward-looking statements are reasonable; there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including, without limitation, risks with respect to: obtaining all necessary regulatory approvals for the transaction with FFD; general economic conditions in Canada and globally; film industry conditions; competition for, among other things, capital and skilled personnel; changes in economic and market conditions that could lead to reduced spending on 3D film conversion; potential delays or changes in plans with respect to deployment of services or capital expenditures; our ability to hire and retain qualified employees and key management personnel; possibility that government policies or laws may change; amount and timing of operating costs and capital expenditures; the ability of the Company to obtain operating capital when needed, the success of certain business combinations engaged in by the Company or by its competitors; possible disruptive effects of organizational or personnel changes; technological change, new products and standards; risks related to acquisitions and international expansion; reliance on large customers; reliance on a limited number of suppliers; risks related to the Company's competition; the Company's failure to adequately protect its intellectual property; interruption or failure of information technology systems; the risk that the FFD transaction may not be completed as planned, or at all; and business, legal and/or regulatory risks relating to Gener8's business, financings and strategic acquisitions. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES 

SOURCE: Gener8 Media Corp.